Comparison of Two Anti-HIV Regimens That Include One of Two Forms of Didanosine (ddI)

PHASE3CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

March 31, 1999

Primary Completion Date

March 31, 1999

Study Completion Date

March 31, 1999

Conditions
HIV Infections
Interventions
DRUG

Nelfinavir mesylate

DRUG

Stavudine

DRUG

Didanosine

Trial Locations (24)

11374

Anderson Clinical Research Inc, Rego Park

19604

Anderson Clinical Research Inc, Reading

29464

Coastal Carolina Research Ctr, Mt. Pleasant

33139

South Shore Hosp, Miami

33306

Community Health Care, Fort Lauderdale

33311

Immunity Care and Research Inc, Fort Lauderdale

33316

HIV Clinical Research Ctr, Fort Lauderdale

33607

Saint Josephs Comprehensive Research Institute, Tampa

35203

Sorra Research Ctr / Med Forum, Birmingham

60610

Chicago Ctr for Clinical Research, Chicago

75219

Oak Lawn Physicians Group, Dallas

75246

Nicholaos Bellos, Dallas

77006

Houston Clinical Research Network / Div of Montrose Clinic, Houston

80304

Beacon Clinic / Boulder Community Hosp, Boulder

89128

Clinical Studies of Las Vegas, Las Vegas

94609

Robert Scott MD, Oakland

98122

Swedish Med Ctr, Seattle

303081962

AIDS Research Consortium of Atlanta, Atlanta

672143124

Univ of Kansas School of Medicine, Wichita

681985400

Univ of Nebraska Med Ctr, Omaha

752359103

Univ of Texas Southwestern Med Ctr of Dallas, Dallas

900276069

AIDS Healthcare Foundation, Los Angeles

Unknown

Clinique Medicale du Quartier Latin, Montreal

Clinique Medicale L'Actuele, Montreal

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY